PCVX R&D Expenses
Vaxcyte Inc · R&D Expenses
PCVX R&D Expenses
Latest reported$1.03Bperiod ending
PCVX R&D Expenses ($12.79M → $1.03B)
Annual R&D Expenses
High-resolution chart · PNG
PCVX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 794,306,000 | |
| 476,644,000 | |
| 332,341,000 | |
| 169,451,000 | |
| 78,411,000 | |
| 73,564,000 | |
| 45,607,000 | |
| 30,145,000 | |
| 12,785,000 |